3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
30
Leukemia, B-Cell
10
Lymphoma
9
Leukemia
8
Recurrence
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
7
Neoplasms
6
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Waldenstrom Macroglobulinemia
3
Burkitt Lymphoma
3
Lymphoma, B-Cell, Marginal Zone
2
Bronchiolitis Obliterans Syndrome
2
Thrombocytopenia
1
Paraproteinemias
1
Oncology Patients Receiving Chemotherapy
1
Lymphoma, B-Cell
1
Lymphocytosis
1
Lymphadenopathy
1
Leukemia, Prolymphocytic
1
Leukemia, Lymphoid
1
Fever
1
Fatigue
1
Agammaglobulinemia
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
ofatumumab
×
Clear all
No trials found.